Paper30012349
AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.
Penning TM. Mol Cell Endocrinol, 2019. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders. Papers, record 30012349. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30012349
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldo-Keto Reductase Family 1 Member C3 | Major topic |
| Endocrine Gland Neoplasms | Major topic |
| Endocrine System Diseases | Major topic |
| Enzyme Inhibitors | |
| Epigenesis, Genetic | |
| Humans | |
| Steroids |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 ES013508 | NIEHS NIH HHS | United States | P30ES013508 | PubMed and NIH | NIH RePORTER |
| R01 CA090744 | NCI NIH HHS | United States | R01CA090744 | PubMed and NIH | NIH RePORTER |
References97
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14764825 | Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. | J Clin Endocrinol Metab | 2004 | https://conductscience.org/library/papers/14764825 | PubMed |
| 2 | 20386893 | Functional significance may underlie the taxonomic utility of single amino acid substitutions in conserved proteins. | J Mol Evol | 2010 | https://conductscience.org/library/papers/20386893 | PubMed |
| 3 | 17874044 | In situ production of sex steroids in human breast carcinoma. | Med Mol Morphol | 2007 | https://conductscience.org/library/papers/17874044 | PubMed |
| 4 | 20086173 | Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer. | Cancer Res | 2010 | https://conductscience.org/library/papers/20086173 | PubMed |
| 5 | 16510604 | Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/16510604 | PubMed |
| 6 | 9521675 | Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases. | Biochemistry | 1998 | https://conductscience.org/library/papers/9521675 | PubMed |
| 7 | 1310260 | 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. | Cell | 1992 | https://conductscience.org/library/papers/1310260 | PubMed |
| 8 | 12975479 | Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. | J Clin Invest | 2003 | https://conductscience.org/library/papers/12975479 | PubMed |
| 9 | 26312838 | Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome. | Lancet | 2015 | https://conductscience.org/library/papers/26312838 | PubMed |
| 10 | 17145895 | 17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/17145895 | PubMed |
| 11 | 26122708 | Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. | Free Radic Biol Med | 2015 | https://conductscience.org/library/papers/26122708 | PubMed |
| 12 | 8381967 | Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8381967 | PubMed |
| 13 | 24571686 | AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression. | Diagn Pathol | 2014 | https://conductscience.org/library/papers/24571686 | PubMed |
| 14 | 20398925 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. | Lancet | 2010 | https://conductscience.org/library/papers/20398925 | PubMed |
| 15 | 17950253 | An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3alpha-HSD, type 5 17beta-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies. | Biochem Pharmacol | 2008 | https://conductscience.org/library/papers/17950253 | PubMed |
| 16 | 23995860 | Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23995860 | PubMed |
| 17 | 21795608 | Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21795608 | PubMed |
| 18 | 9307009 | Comparative anatomy of the aldo-keto reductase superfamily. | Biochem J | 1997 | https://conductscience.org/library/papers/9307009 | PubMed |
| 19 | 17611413 | MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma. | Cell Cycle | 2007 | https://conductscience.org/library/papers/17611413 | PubMed |
| 20 | 23196782 | Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer. | Mol Med | 2013 | https://conductscience.org/library/papers/23196782 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42573019 | Synthesis and Activity-Based Protein Profiling Identifies Aldo-Keto Reductase 1C3 as Target Protein of Myxoglucamides. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42573019 | PubMed |
| 42561036 | Uncovering the molecular landscape of young-onset diffuse gastric cancer: A relieff-based feature selection analysis on RNA-Seq data. | PLoS One | 2026 | https://conductscience.org/library/papers/42561036 | PubMed |
| 42412303 | From Gene Function to Precision Intervention: CRISPR/Cas9 and Stem Cell-Based Strategies as Emerging Disease-Modifying Approaches in PMOS. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42412303 | PubMed |
| 42396977 | AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review (2020-present). | Expert Opin Ther Pat | 2026 | https://conductscience.org/library/papers/42396977 | PubMed |
| 42297903 | Target-driven machine learning-enabled virtual screening (TAME-VS) enables prioritization of AKR1C3 inhibitors. | Commun Chem | 2026 | https://conductscience.org/library/papers/42297903 | PubMed |
| 42151495 | Single-cell and spatial transcriptomics reveal an arachidonic acid-related cellular atlas in lung adenocarcinoma. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42151495 | PubMed |
| 41735769 | Androgen metabolism in prostate cancer: recent advances. | Endocrinology | 2026 | https://conductscience.org/library/papers/41735769 | PubMed |
| 41735359 | Cancer-Associated fibroblasts regulate the development of cholangiocarcinoma through IL-6/STAT3/AKR1C3 signaling axis. | Sci Rep | 2026 | https://conductscience.org/library/papers/41735359 | PubMed |
| 41193657 | Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer. | Nat Genet | 2025 | https://conductscience.org/library/papers/41193657 | PubMed |
| 40489436 | Aldo-keto reductase family 1 member C3 (AKR1C3) gene polymorphism (rs12529) is associated with breast cancer in Bangladeshi population: A case-control study and computational investigation. | PLoS One | 2025 | https://conductscience.org/library/papers/40489436 | PubMed |
| 40278368 | Steroids Static Postural Balance Changes After Exercise Intervention Correlate with Steroidome in Elderly Female. | Metabolites | 2025 | https://conductscience.org/library/papers/40278368 | PubMed |
| 40130571 | A case of familial partial lipodystrophy type 2 masquerading as Cushing syndrome: Explaining an atypical phenotype by whole-exome sequencing. | Arch Endocrinol Metab | 2025 | https://conductscience.org/library/papers/40130571 | PubMed |
| 40055914 | AKR1C3 protects cardiomyocytes against hypoxia-induced cell apoptosis through the Nrf-2/NF-κB pathway. | Acta Biochim Biophys Sin (Shanghai) | 2025 | https://conductscience.org/library/papers/40055914 | PubMed |
| 39834787 | Identification and validation of five ferroptosis-related molecular signatures in keloids based on multiple transcriptome data analysis. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39834787 | PubMed |
| 39733054 | Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies. | Prostate Cancer Prostatic Dis | 2026 | https://conductscience.org/library/papers/39733054 | PubMed |
| 39632995 | AKR1C3 mediates gastric cancer cell invasion and metastasis via the AKT and JNK/p-NF-κB signaling pathways. | Sci Rep | 2024 | https://conductscience.org/library/papers/39632995 | PubMed |
| 39572849 | Reversible downregulation of MYC in a spheroid model of metastatic epithelial ovarian cancer. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/39572849 | PubMed |
| 39505850 | The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia. | Blood Cancer J | 2024 | https://conductscience.org/library/papers/39505850 | PubMed |
| 39177862 | Identification of Pyroptosis-Related Molecular Subtypes and Diagnostic Model development in Major Depressive Disorder. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/39177862 | PubMed |
| 39163853 | Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway. | Cell Chem Biol | 2025 | https://conductscience.org/library/papers/39163853 | PubMed |
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30012349
GET https://conductscience.org/api/papers/v1/30012349/references?page=2